NCT05489640

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

A Real-World Study to Determine Patient Characteristics, Treatment Patterns, Clinical and Patient-Reported Outcomes of Patients With Hereditary Angioedema That Self-Administered Icatibant Using Homecare Services in the UK

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 85 (actual)
• Sponsor: Takeda · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The main aim of this study is to describe the treatment patterns, characteristics and outcomes of people with HAE who are currently receiving icatibant in the homecare setting in the United Kingdom (UK). Participants will be treated with icatibant according to their routine practice via homecare service for icatibant within the UK. Data will be directly collected from participants via study diaries and questionnaires. Participants will be contacted approximately every 90 days during study duration (this can occur via phone or as a face-to-face visit).

Conditions

• Hereditary Angioedema (HAE)

Interventions

Type	Name	Description
OTHER	No Intervention	No Intervention will be administered in this study.

Timeline

• Start date: 2022-11-18
• Primary completion: 2024-07-17
• Completion: 2024-07-17
• First posted: 2022-08-05
• Last updated: 2024-08-05

Locations

1 site across 1 country: United Kingdom